Satellite images and videos of an Iranian girls school damaged by large explosions at the start of a U.S.-Israeli airstrike ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

Chewy is expanding beyond pet e-commerce into vet clinics, telehealth, insurance and ads, aiming to deepen engagement, boost ...

Nonenal odor can start as early as age 40, and normal soap can't get rid of it.

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 ...

In the United States, software and payments convergence already dominates SME commerce. In Europe, fragmentation and ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

When ICE officers in Minneapolis detained a 5-year-old boy and his father last month and sent them to a Texas detention ...

Hydreight Technologies Inc. (TSXV: NURS) (OTC: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a leader in U.S. nationwide digital healthcare infrastructure and mobile clinical services, today ...

Katherine Shields' medication for diabetes insipidus is running out across Canada after a disruption in manufacturing.